IDE# G150194: A Prospective, Multicenter, Single-Arm Study Designed to Assess the Safety of 3-Month Dual Antiplatelet Therapy (DAPT) in Subjects at High Risk for Bleeding Undergoing Percutaneous Coronary Intervention (PCI) with the SYNERGYTM Everolimus-El

Project: Research project

StatusActive
Effective start/end date2/1/172/1/20

Funding

  • Boston Scientific Corporation (IDE# G150194)